Reference

1. Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, FernándezCapitán C, et al. Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: Study protocol for a randomized controlled trial. Trials. 2012;13(239):239.
2. Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325: 1073–5.
3. F. Dentali, W. Ageno et al. Treatment of coumarin-associated Coagulopathy: a systematic review and proposed treatment algorithms Journal of Thrombosis and Haemostasis, 2006, 4: 1853–1863.
4. Fredenburgh JC, Weitz JI. Factor XI as a target for new anticoagulants. Hämostaseologie. 2021 Apr;41(02):104-10.
5. Lüscher TF, Davies A, Beer JH, Valgimigli M, Nienaber CA, Camm JA, Baumgartner I, Diener HC, Konstantinides SV. Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum. European heart journal. 2022 Mar 7;43(10):940-58.
6. Rosand J Eckman MH Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004.
7. Kirshner H, Schrag M. Management of intracerebral hemorrhage: update and future therapies. Current Neurology and Neuroscience Reports. 2021 Oct;21:1-5.
8. Hankins GD, Koen S, Gei AF, Lopez SM, Van Hook JW, Anderson GD. Neonatal organ system injury in acute birth asphyxia sufficient to result in neonatal encephalopathy. Obstet Gynecol. (2002) 99(5 Pt 1):688–91.
9. Cendes F, Theodore WH, Brinkmann BH, Sulc V, Cascino GD. Neuroimaging of epilepsy. Handbook of clinical neurology. 2016 Jan 1;136:985-1014.
10. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991 Jul 1;41(7):965-.
11. Roberts MA, Godfrey JW. Epileptic seizures in the elderly. I. Aetiology and type of seizure. Age and Ageing 1982;11:24–8.
12. Myint PK, Staufenberg EFA, Sabanathan K. Post-stroke seizure and post-stroke epilepsy. Postgraduate Medical Journal 2006;82:568–72.
13. Nakken KO, Refsland G, Lillestølen KM, Solaas MH. Seizure-precipitating factors in epilepsy-- what do patients report?. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. 2005 Aug 1;125(16):2172-4.
14. Sánchez S, Rincon F. Status epilepticus: epidemiology and public health needs. Journal of clinical medicine. 2016 Aug 16;5(8):71.
15. Alvarez V, Rossetti AO. Clinical Consequences of Generalized Convulsive Status Epilepticus. Status Epilepticus: A Clinical Perspective. 2018:111-21.
16. Neuenfeldt FS, Weigand MA, Fischer D. Coagulopathies in intensive care medicine: balancing act between thrombosis and bleeding. Journal of clinical medicine. 2021 Nov 18;10(22):5369.
17. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J. Thromb. Haemost. 4(9), 1853–1863 (2006).
18. O'Shaughnessy DF, Atterbury C ,Bolton MP, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant., Br J Haematol, 2004, vol. 126 1(pg. 11- 28)
19. Riess HB, Meier-Hellmann A, Motsch J, Elias M, Kursten FW, Dempfle CE. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb. Res. 121(1), 9–16 (2007).
20. Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N. Engl. J. Med. 349(7), 675–683 (2003).
21. Rahim F, Azizimalamiri R, Sayyah M, Malayeri A. Experimental therapeutic strategies in epilepsies using anti-seizure medications. Journal of experimental pharmacology. 2021 Mar 11:265-90.
22. Isaeva E., Hernan A., Isaev D., Holmes G. L. (2012). Thrombin facilitates seizures through activation of persistent sodium current. Ann. Neurol. 72 192–198.
23. Yang S, Wang B, Han X. Models for predicting treatment efficacy of antiepileptic drugs and prognosis of treatment withdrawal in epilepsy patients. Acta Epileptologica. 2021 Dec; 3:1-6